European Network for Rare and Congenital Anaemias

Translate

ENERCA means easy access to a high quality information on rare anaemias for patients, citizens, health professionals, stakeholders, authorities and pharmaceutical industry.

News

Combination of EMA-binding and AGLT tests shows the highest diagnostic power for hereditary spherocytosis

2012-01-24

In hereditary spherocytosis, as in many other rare diseases, one of the challenges is developing a reliable diagnostic tool. The team from the Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico (Milan), led by Prof. Alberto Zanella, has undergone a performance comparison of several tests to determine which of them is the most useful diagnostic method.
Collaborate with the ENERCA questionnaires for professionals

2011-12-22

ENERCA is a network that needs your collaboration. One of the many ways to collaborate with this project is by answering the questionnaires for professionals you will find in the Activities section of our website.